FDA Inspection
Bioreliance Ltd.Bioreliance Ltd. – FDA Inspection, Mar 21, 2019
Record Details
This FDA Inspection record concerns Bioreliance Ltd., with an inspection on March 21, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · b50e7b96-afd3-494e-b2cf-716caad515c2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1088154
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Bioreliance Ltd.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 30, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 10, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2016 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 18, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bioreliance Ltd.
- FDA Inspection 1223799 - 2023-11-07
- FDA Inspection 1202973 - 2022-06-30
- FDA Inspection 1066803 - 2017-10-10
- FDA Inspection 976603 - 2016-03-17
- FDA Inspection 890477 - 2014-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.